Our Strategy and Values

The commercial strategy of the Group has a number of key elements:

Our Strategy


To make our lead product Feraccru® / Accrufer™ (Ferric Maltol) available to as many patients as possible in collaboration with commercial partners


Effectively use clinical and pharmaco-economic data to support commercial partners


Engage with a well-resourced and ambitious partner to enable commercial success in the US market for Accrufer®


Establish Feraccru® / Accrufer™ (Ferric Maltol) as the first choice for patients who have failed salt-based oral iron treatment


To maintain a scalable supportive infrastructure that facilitates product development and commercial success


To evaluate opportunities to out-licence PT20 to an attractive commercial partner

Our Values

  • Patient centric: The patients our therapies treat are at the heart of why we do it
  • Ethical: Always professional with the highest of standards
  • Product focused: We have a great track record of identifying value and are always looking for more
  • Freedom to operate: It is “our” Company and we avoid hierarchy, we challenge to succeed
  • Relationships: Strong and human… everyone is valuable
  • Continuously develop: We only want people who are committed, effective and determined to succeed